In vitro radiosensitization by pentoxifylline does not depend on p53 status

International Journal of Radiation Biology

Volumn 89, Issue 6, 2013, Pages 462-470

  Akudugu, John M ^a   Serafin, Antonio M ^a   Böhm, Lothar J F ^a  

^a UNIVERSITY OF STELLENBOSCH   (South Africa)

Author keywords

G2 M block; P53 status; Pentoxifylline; Radiosensitization

Indexed keywords

COBALT 60; PENTOXIFYLLINE; PROTEIN P53;

ARTICLE; CANCER CELL CULTURE; CELL CYCLE G1 PHASE; CELL CYCLE S PHASE; CELL MUTANT; CELL POPULATION; CELL SURVIVAL; CONTROLLED STUDY; FLOW CYTOMETRY; G2 PHASE CELL CYCLE CHECKPOINT; GLIOBLASTOMA; HUMAN; HUMAN CELL; IN VITRO STUDY; IONIZING RADIATION; MICRONUCLEUS TEST; MITOSIS RATE; PRIORITY JOURNAL; RADIATION DOSE; RADIOSENSITIVITY; RADIOSENSITIZATION;

CELL LINE, TUMOR; CELL SURVIVAL; GLIOBLASTOMA; HUMANS; PENTOXIFYLLINE; RADIATION TOLERANCE; RADIATION-SENSITIZING AGENTS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84878613271     PISSN: 09553002     EISSN: 13623095     Source Type: Journal    
DOI: 10.3109/09553002.2013.766771     Document Type: Article

References (45)

1. Akudugu JM, Bell RS, Catton C, Davis AM, Griffi n AM, O'Sullivan B, Waldron JN, Ferguson PC, Wunder JS, Hill RP . 2006. Wound healing morbidity in STS patients treated with preoperative radiotherapy in relation to in vitro skin fi broblast radiosensitivity, proliferative capacity and TGF- ® activity. Radiotherapy and Oncology 78: 17- 26
2. Akudugu JM, Theron T, Serafi n AM, B o hm L . 2004 . Influence of DNA double-strand break rejoining on clonogenic survival and micronucleusý ield in human cell lines . International Journal of Radiation Biology 80 : 93 - 104
3. Akudugu JM, Slabbert JP . 2008. Modulation of radiosensitivity in Chinese hamster lung fi broblasts by cisplatin . Canadian Journal of Physiology and Pharmacology 86: 257- 263
4. Akudugu JM, Slabbert JP, Serafi n A, B o hm L . 2000 . Frequency of radiation-induced micronuclei in neuronal cells does not correlate with clonogenic survival. Radiation Research 153: 62- 67
5. Anker L, Ohgaki H, Ludeke BI, Herrmann H-D, Kleihues P, Westphal M . 1993 . p53 protein accumulation and gene mutations in human glioma cell lines . International Journal of Cancer 55 : 982 - 987
6. Aylon Y, Ofi r-Rosenfeld Y,ýabuta N, Lapi E, Nojima H, Lu X, Oren M. 2010. The Lats2 tumor suppressor augments p53-mediated apoptosis by promoting the nuclear proapoptotic function of ASPP1 . Genes & Development 24: 2420- 2429
7. Bache M, Pigorsch S, Dunst J, W url P, Meye A, Bartel F, Schmidt H, Rath FW, Taubert H . 2001 . Loss of G2/M arrest correlates with radiosensitization in two human sarcoma cell lines with mutant p53 . International Journal of Cancer 96: 110- 117
8. Binder AB, Serafi n AM, B o hm LJF . 2000 . Abrogation of G2/M-phase block enhances the cytotoxicity of daunorubicin, melphalan and cisplatin in TP53 mutant human tumour cells . Radiation Research 154 : 640 - 649
9. Binder A, Theron T, Donninger H, Parker M, Bohm L . 2002. Radiosensitization and DNA repair inhibition by pentoxifylline in NIH3T3 p53 transfectants . International Journal of Radiation Biology 78 : 991- 1000
10. Bohm L . 2006 . Inhibition of homologous recombination repair with pentoxifylline targets G2 cells generated by radiotherapy and induces major enhancements of the toxicity of cisplatin and melphalan given after irradiation. Radiation Oncology 1: 12
11. Bohm L, Theron T, Binderá. 2000. Influence of pentoxifylline, A-802710, propentofylline and A-802715 (Hoechst) on the expression of cell cycle blocks and S-phase content after irradiation damage . Biochimica et Biophysica Acta 1499: 1- 10
12. Bohm L, Roos WP, Serafi n AM . 2003 . Inhibition of DNA repair by pentoxifylline and related methylxanthine derivatives . Toxicology 193 : 153 - 160
13. Clarke AR, Purdie CA, Harrison DJ, Morris RG, Bird CC, Hooper ML, Wyllie AH . 1993 . Thýmocyte apoptosis induced by p53 -dependent and independent pathways . Nature 362 : 849 - 852
14. El-Deiry WS, Harper JW, O'Connor PM, Velculescu VE, Canman CE, Jackman J, Pietenpol JA, Burrell M, Hill DE, Wang Y, Wiman KG, Mercer WE, Kastan MB, Kohn KW, Elledge SJ, Kinzler KW, Vogelstein B . 1994 WAF1/CIP1 is induced in p53-mediated G1 arrest and apoptosis. Cancer Research 54: 1169- 1174
15. Eley KW, Benedict SH, Chung TDK, Kavanagh BD, Broaddus WC, Schmidt-Ullrich RKA, Lin P-S . 2002. The eff ects of pentoxifylline on the survival of human glioma cells with continuous and intermittent stereotactic radiosurgery irradiation . International Journal of Radiation Oncology, Biology, and Physics 54: 542- 550
16. Hermeking H, Fick D . 1994. Mediation of c-myc -induced apoptosis by p53 . Science 265 : 2091 - 2093
17. Hwang A, Muschel RJ . 1998. Radiation and the G2 phase of the cell cycle . Radiation Research 150: S52- S59
18. Kastan MB, Onyekwere O, Sidransky D, Vogelstein B, Graig RW . 1991 Participation of p53 protein in the cellular response to DNA damage. Cancer Research 51: 6304- 6311
19. Kawabe T . 2004. G2 checkpoint abrogators as anticancer drugs . Molecular Cancer Th erapeutics 3: 513- 51
20. Kim SH, Khil MS, Ryu S, Kim JH . 1993. Enhancement of radiation response on human carcinoma cell lines in culture by pentoxifylline. International Journal of Radiation Oncology, Biology, and Physics 25 : 61 - 65
21. Kim EL,ýoshizato K, Kluwe L, Meissner H, Warnecke G, Zapf S, Westphal M, Deppert W, Gieseá. 2005. Comparative assessment of the functional p53 status in glioma cells . Anticancer Research 25 : 213 - 224
22. Kraus A, Gross MW, Knuechel R, M unkel K, Neff F, Schlegel J . 2000 Aberrant p21 regulation in radioresistant primary glioblastoma multiforme cells bearing wild-type p53 . Journal of Neurosurgery 93 : 863 - 872
23. Kuerbitz SJ, Plunkett BS, Walsh WV, Kastan MB . 1992 . Wild-type p53 isácell cycle checkpoint determinant following irradiation . Proceedings of the National Academy of Sciences of the USA 89 : 7491 - 7495
24. Liý-X, Weber-Johnston K, Sun L-Q, Paschoud N, Mirimanoff R-O, Coucke PA . 1998. Eff ect of pentoxifylline in radiation-induced G2-phase delay and radiosensitivity of human colon and cervical cancer cells . Radiation Research 149: 338- 342
25. Linke SP, Clarkin KC, Wahl GM . 1997 . P53 mediates permanent arrest over multiple cell cycles in response to © -irradiation. Cancer Research 57: 1171- 1179
26. Lossaint G, Besnard E, Fisher D, Piette J, Duli ć V . 2011 . Chk1 is dispensable for G2 arrest in response to sustained DNA damage when the ATM/p53/p21 pathway is functional . Oncogene 30 : 4261 - 4274
27. Lowe SW, Schmitt EM, Smith SW, Osborne BA, Jacks T . 1993. p53 is required for radiation-induced apoptosis in mouse thymocytes. Nature 362 : 847 - 849
28. Mellert HS, Stanek TJ, Sykes SM, Rauscher III FJ, Schultz DC, McMahon SB . 2011 . Deacetylation of the DNA-binding domain regulates p53-mediated apoptosis . The Journal of Biological Chemistry 286 : 4264 - 4270
29. Mokaleng BB, Akudugu JM . 2009. Modulation of the sensitivity in Chinese hamster cells to photons and fast neutrons by cisplatin, vinblastine and bleomycin . Canadian Journal of Physiology and Pharmacology 87 : 347- 352
30. O'Connor PM . 1997. Mammalian G1 and G2 phase checkpoints. Cancer Surveys 29 : 151 - 82
31. O'Connor PM, Jackman J, Jondle D, Bhatia K, Magrath I, Kohn KW. 1993 . Role of the p53 tumor suppressor gene in cell cycle arrest and radiosensitivity of Burkitt's lymphoma cell lines . Cancer Research 53 : 4776 - 4780
32. O'Connor MJ, Martin NMB, Smith GCM . 2007. Targeted cancer therapies based on the inhibition of DNA strand break repair . Oncogene 26 : 7816 - 7824
33. Ono K, Masunaga S, Akaboshi M, Akuta K . 1994. Estimation of the initial slope of the cell survival curve after irradiation from micronucleus frequency in cytokinesis-blocked cells . Radiation Research 138: S101- S104
34. Russell KJ, Wiens LW, Demers GW, Galloway DA, Le T, Rice GC, Bianco JA, Singer JW, Groudine M . 1996. Preferential radiosensitisation of G1 checkpoint-defi cient cells by methylxanthines . International Journal of Radiation Oncology, Biology, and Physics 36 : 1099 - 1106
35. Sayan BS, Sayan AE, Knight RA, Melino G, Cohen GM . 2006. p53 is cleaved by caspases generating fragments localizing to mitochondria. The Journal of Biological Chemistry 281 : 13566 - 13573
36. Stark GR, Taylor WR . 2006 . Control of the G2/M transition . Molecular Biotechnology 32 : 227 - 248
37. Smith RV, Waller ES, Doluisio JT, Bauza MT, Puri SK, Ho I, Lassman HB . 1986 . Pharmacokinetics of orally administered pentoxifylline in humans . Journal of Pharmaceutical Sciences 75: 47- 52
38. Strunz AM, Peschke P, Debus J, Waldeck W, Ehemann V, Kissel M . 2002 Preferential radiosensitization in p53-mutated human tumour cell lines by pentoxifylline-mediated disruption of the G2/M checkpoint control . International Journal of Radiation Biology 78 : 721 - 732
39. Taylor WR, Stark GR . 2001. Regulation of the G2/M transition by p53. Oncogene 20 : 1803 - 1815
40. Theron T, B o hm L . 1998 . Cyclin B1 expression in response to abrogation of the radiation-induced G 2 /M block in HeLa cells . Cell Proliferation 31 : 49 - 57
41. Theron T, B o hm L . 2000 . Influence of the G2 cell cycle block abrogator pentoxifylline on the expression and subcellular location of cyclin B1 and p34 cdc2 in HeLa cervical carcinoma cells . Cell Proliferation 33 : 39 - 50
42. Theron T, Binder A, Verheye-Dua F, Bohm L . 2000. The role of G2-block abrogation, DNA double-strand break repair and apoptosis in the radiosensitisation of melanoma and squamous cell carcinoma cell lines by pentoxifylline . International Journal of Radiation Biology 76 : 1197 - 1208
43. Vernimmen F, Verheye-Dua F, du Toit H, Bohm L . 1994. Eff ect of pentoxifylline on radiation damage and tumour growth . Strahlentherapie und Onkologie 10 : 595 - 601
44. Wagner AJ, Kokontis JM, Hay N . 1994. Myc -mediated apoptosis requires wild-type p53 inámanner independent of cell cycle arrests and the ability of p53 to induce p21 waf1/cdk1 . Genes & Development 8: 2817 - 2830
45. Westphal M, Meissner H . 1998. Establishing human glioma-derived cell lines . In: Mather JP, Barnes D, editors . Methods in cell biology. Vol. 57. Newýork: Pergamon. pp. 147- 165